Altron HealthTech and Dischem Oncology partner to standardise EHR technology

The annual global cost of cancer stands at $895 billion, with 44% of new cancer drugs launched since 2019 priced at over $200,000. Amidst this landscape, Altron HealthTech and Dischem Oncology are collaborating to address challenges in oncology care, emphasising digital health innovation. The collaboration aims to provide clinicians with access to digital health advancements that can transform infrastructure, reduce costs, and improve patient-clinician interactions. Recognising the operational challenges faced by oncologists, the focus is on standardising Electronic Health Record (EHR) data to enable interoperability, enhance patient access to health data, and establish payment reforms.

The goal is to create an ecosystem that streamlines clinician workflows, integrates pathology data, issues early warnings on expiring treatment plans, and ensures customisable workflows by clinicians, nurses, authorisation teams, and pharmacists. The solution is designed to reduce the administrative burden on clinicians while improving the quality of care and operational efficiencies. By leveraging interconnected technology, the collaboration aims to bring transparency and visibility to the oncology ecosystem, allowing stakeholders to work together in controlling medical costs and envisioning a new future for oncology care.

Altron HealthTech and Dischem Oncology's collaboration aligns clinical workflows and treatment plans with industry protocols, potentially leading to cost reductions and improved efficiencies. The initiative highlights the potential for digital health technologies to transform cancer care by providing clinicians with tools that enhance their roles and improve patient support across cost and quality of care.